text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023.03.31\n)\n(단위 : 백만원, 천주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n(주)비덴트\n상장\n2019.11.16\n단순투자\n55,001\n11,002\n18.58\n113,375\n-\n-\n4,169\n11,002\n18.58\n117,544\n712,441\n2,036\n(주)하임바이오\n비상장\n2020.11.20\n사업다각화\n5,000\n3,975\n20.69\n\xa0 \xa0 \xa0 \xa0 \xa0-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 -\n3,975\n20.69\n\xa0 \xa0 \xa0 \xa0 \xa0-\n5,594\n-3,724\nGenoplan Inc\n비상장\n2020.12.31\n사업다각화\n10,007\n233\n8.85\n-\n-\n-\n-\n233\n8.85\n-\n5,888\n-6,770\n쿼드콜라보오퍼스2 투자조합\n비상장\n2022.06.07\n단순투자\n550\n0\n1.98\n486\n-\n-\n-\n0\n1.98\n486\n25,894\n-733\n(주)리케어랩\n비상장\n2022.09.30\n사업다각화\n240\n480\n48.0\n168\n-\n-\n\xa0 \xa0 \xa0 \xa0-52\n480\n48.0\n116\n290\n-108\n합 계\n-\n-\n114,029\n-\n-\n4,117\n15,690\n-\n118,146\n-\n-\n※ 쿼드콜라보 오퍼스2 투자조합 취득 주식은 500좌 입니다.\n']"
